Dormant
MMYT · MakeMyTrip Limited
Last analysed ·
Resolved Graded and closed 2026-07-24 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
MakeMyTrip's mid-year recovery bounce has stalled: after reclaiming the 200-day near $55, MMYT rolled back to ~$49, below both the 50- and 200-day, straight into an August 3 Q1 FY2027 print where consensus models EPS down ~76% YoY on ~137x trailing earnings. A maturing India-OTA leader where the binary print, not the chart, sets the next leg — the setup does not clear ahead of the print.
Kill line
A weekly close below $46 loses the 50-day and the last recovery shelf, dropping the bounce back into the $33–46 base; a soft August 3 Q1 FY2027 print confirming deeper take-rate/margin compression and stalled air-ticketing flips the theme from recovery to decelerating.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for MMYT —
As of 20 September 2026, the latest FrontierPicks analysis for MakeMyTrip Limited (MMYT): MakeMyTrip's mid-year recovery bounce has stalled: after reclaiming the 200-day near $55, MMYT rolled back to ~$49, below both the 50- and 200-day, straight into an August 3 Q1 FY2027 print where consensus models EPS down ~76% YoY on ~137x trailing earnings. A maturing India-OTA leader where the binary print, not the chart, sets the next leg — the setup does not clear ahead of the print.
Kill line: A weekly close below $46 loses the 50-day and the last recovery shelf, dropping the bounce back into the $33–46 base; a soft August 3 Q1 FY2027 print confirming deeper take-rate/margin compression and stalled air-ticketing flips the theme from recovery to decelerating.
Next dated event on file: — catalyst in 8d.
Current Thesis
MakeMyTrip's recovery case requires booking growth to withstand weaker Indian air traffic and the shares to regain the 2026-09-04 close of $55.62 before a weekly close below $46. The operating premise remains the 19.9% constant-currency gross-bookings growth reported for the June quarter on 2026-08-03; the next quarterly results must establish whether that growth persists.
The measured change since the September 6 assessment is deterioration: the adjusted reference close was $47.92 on 2026-09-18, versus the previously documented $55.62 on 2026-09-04. A report published on 2026-09-19 also attributes a 6% year-over-year decline in August domestic passengers to India's Directorate General of Civil Aviation (DGCA). That is additional industry weakness, although passenger counts do not directly measure MakeMyTrip's booking value. August traffic report
The life-cycle assessment is an inference: the narrative is maturing — the August 3 results are established information, while the September 17 headline republishes a first-quarter earnings transcript rather than announcing another quarter. The recovery case has low conviction because the latest close has already breached the earlier $53 warning threshold, although it remains above the published $46 thesis-break threshold. September 17 transcript
Bullish and bearish views on MakeMyTrip Limited
The model's bull view on MakeMyTrip Limited (MMYT), in brief: Growth extended beyond air travel. The 2026-08-03 first-quarter release reported gross bookings of $2,854.7 million, up 19.9% in constant currency. Hotels and packages grew 19.6% and bus ticketing grew 31.4% on the same measure, providing operating evidence beyond the airline… The bear view: Industry volumes weakened again. DGCA data reported by Free Press Journal on 2026-09-19 put August domestic passengers at 1.21 crore, down 6% year over year. This follows July's 4.80% decline in the previously published DGCA data; those observations establish recent weakness… Both cases follow in full.
Bull Case
- Growth extended beyond air travel. The 2026-08-03 first-quarter release reported gross bookings of $2,854.7 million, up 19.9% in constant currency. Hotels and packages grew 19.6% and bus ticketing grew 31.4% on the same measure, providing operating evidence beyond the airline segment. Company release
- Adjusted earnings exceeded the comparison. The August 3 Benzinga earnings wire cited adjusted diluted earnings per share of $0.53 against consensus of $0.45 for the quarter ended 2026-06-30. This supports the adjusted-profitability case, but does not resolve the separate decline in reported profit documented in that quarter's company release.
Bear Case
- Industry volumes weakened again. DGCA data reported by Free Press Journal on 2026-09-19 put August domestic passengers at 1.21 crore, down 6% year over year. This follows July's 4.80% decline in the previously published DGCA data; those observations establish recent weakness, but the sample is too small to establish a durable demand trend. August traffic report
- Financing absorbed operating progress. The 2026-08-03 release reported June-quarter profit of $9.1 million versus $25.8 million a year earlier, with net finance costs of $28.3 million versus $4.0 million. The reported-profit recovery remains unconfirmed despite booking growth. Company release
Setup & Price Structure
The supplied adjusted market series records a 2026-09-18 close of $47.92, a three-month price increase of 4.0%, and a price 53.0% below its 52-week high. The 14-period relative strength index (RSI) was 17.9. These are measurements of price and momentum; they do not establish that a rebound has begun. Current moving-average levels and trading-volume comparisons are unavailable.
The September 6 assessment's $53 warning threshold has been breached by the September 18 weekly-ending close. The separate $46 thesis-break threshold remains the published analytical boundary; it is not presented as a currently verified moving average or fresh support. Regaining the historical September 4 close of $55.62 before that boundary fails defines the price-recovery case.
Coverage remains bullish in an observable, limited sense: Zacks reported six Strong Buy recommendations among eight brokerage recommendations on 2026-09-10. That measures analyst opinion, not investor exposure. The available evidence does not establish retail crowding, current short interest, or insider transactions during the decline. Zacks recommendation survey
Catalyst Calendar (next 30 days)
- 2026-09-28 — Annual general meeting. The company's August 7 notice schedules the meeting for 5:00 p.m. Indian Standard Time. Its agenda includes the annual report and auditor appointment; the notice does not promise a trading update or earnings release. Filed meeting notice
- ~2026-10-28, estimated — Quarterly results. This remains an unconfirmed calendar estimate from the September 6 assessment, outside the next 30 days. Results for the quarter ending 2026-09-30 are the substantive test of whether booking growth persists and reported profit improves; the estimated date is not a company commitment.
What Would Change Our Mind
Failure of the remaining recovery boundary ends the price thesis: a weekly close below $46 invalidates the case before recovery to the September 4 close of $55.62. The September 18 close of $47.92 supplies the latest observation against that condition.
The operating case would also fail if the next quarterly release reports a year-over-year contraction in constant-currency gross bookings. Conversely, growth at or above the June quarter's reported 19.9%, accompanied by reported profit above that quarter's $9.1 million, would strengthen the earnings evidence. These are explicit tests against the August 3 release, not forecasts that those outcomes will occur.
Correlation Notes
This remains a single-company recovery case. MakeMyTrip's June-quarter air-ticketing bookings grew 17.7% in constant currency according to its August 3 release, while the September 19 industry report describes declining August domestic passenger counts. The periods, geographic scope and units differ, so their divergence cannot establish market-share gains. Company release August traffic report
Currency is a documented operating exposure: management's first-quarter remarks, published in the September 17 transcript, identified rupee weakness and higher oil prices as travel-cost pressures. That attribution supports monitoring those variables; no measured equity correlation or peer-return series is available to establish a group-driven recovery. Published earnings transcript
Notes
- Foreign private issuer: results arrive on Form 6-K, not 10-Q, so there is no US-style quarterly filing cadence to lean on.
- Functional currency is INR while reporting is in USD; reported and constant-currency growth diverged by ~10pp in Q1 FY2027.
- Adjusted diluted EPS ($0.53) and GAAP diluted EPS ($0.09) differ materially in Q1 FY2027 — check which line a headline quotes.
- Total equity was negative $58,461k at 2026-03-31 with an accumulated deficit of $2,792,733k; there is no book-value floor.
- Convertible senior notes due 2030 drove net finance costs to $28.3M in the June quarter versus $4.0M a year earlier.
- Repurchase authorization has $95.8M remaining and runs through March 2030;
Related · shared themes
GEO
The GEO Group, Inc.
The GEO Group’s detention-contract story depends on year-end 2026 activation, with normalized earnings expected in early 2027. A weekly close above $32.77 would confirm the price leg; a weekly close below $28 or a disclosed activation delay beyond year-end would invalidate the case.
NAVN
Navan, Inc.
Q2 FY2027 prints 2026-09-09 with the first positive non-GAAP operating-income guide ($13.5–14.5M) on the line. Four target raises in 21 days — BofA $26→$34 on 09-02, Morgan Stanley $33 on 09-04 — landed while the shares fell from the $30.58 high to $27.78 on 09-04 and lost the $28.22 August shelf, leaving a maturing narrative whose next bid is decided by one dated print.
ALGT
Allegiant Travel Company
Allegiant closed the $1.5B Sun Country acquisition (2026-05-13) to become the largest US leisure airline just as fuel flipped to a tailwind and the whole sell-side re-rated it to $142–$160; the move has more than doubled off the low, and the first partly-combined Q2 print on 2026-08-04 is the binary.
MCS
The Marcus Corporation
Theatrical-recovery re-rating is drifting sideways with no company input: no release and no target revision since 2026-08-04, leaving consensus at $32.25 while the 2026-08-28 close of $29.02 sits 6.5% under the $31.03 52-week high. Domestic box office reached $7.072B on the 2026-08-30 Box Office Mojo retrieval, but nothing company-dated resolves before the ~2026-11-05 (est.) Q3 print, leaving a maturing narrative in its weakest seasonal quarter.